Skip to content

Clinical trials

Phase 2 Urinary Bladder Neoplasms trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder Neoplasms Phase: Phase 2 Country / region: Japan Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20171
20202
20211
20222
20232
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting6
Completed4
Active, not recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC2
Astellas Pharma Inc1
Bayer1
Boehringer Ingelheim1
Daiichi Sankyo1
Iwate Medical University1
Kyoto University1
Kyoto University Hospital1
Merck Sharp & Dohme LLC1
Nagoya University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder Neoplasms13
Carcinoma, Transitional Cell3
Endometrial Neoplasms3
Esophageal Neoplasms3
Ovarian Neoplasms3
Pancreatic Neoplasms3
Stomach Neoplasms3
Uterine Cervical Neoplasms3
Biliary Tract Neoplasms2
Breast Neoplasms2

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.